Akademik Portal | Prof. Dr. Arzu Oğuz Özgeçmiş Sayfası

Yükleniyor

Prof. Dr. Arzu Oğuz

Tıbbi Onkoloji Bilim Dalı
aoguz[at]baskent.edu.tr
0(312) 246 66 66

H-İndeks 9

• Tıbbi Onkoloji (İç Hastalıkları) • İç Hastalıkları

Birleşmiş Milletler Sürdürülebilir Kalkınma Amaçları

Toplam Yayın : 4

Yayın Bilgileri


1 Brain metastasis of hepatocellular carcinoma- single center experience., INDIAN JOURNAL OF CANCER, 61(2), 2024 Prof. Dr. Arzu Oğuz, Prof. Dr. Özden Altundağ
2 The impact of lymph node ratio on overall survival in patients with colorectal cancer, Journal of Cancer Research and Therapeutics, 8(0), 2020 Prof. Dr. Arzu Oğuz, Gökşen İnanç İmamoğlu, Sanem Çimen, Tülay Eren, Cengiz Karaçin, Dilşen Çolak, Mustafa Altınbaş, Sema Türker, Doğan Yazılıtaş
3 Is Tamoxifen Use a Factor Affecting Continence in Breast Cancer Patients?, Cureus, 11(8), 2020 Prof. Dr. Arzu Oğuz, Gökşen İnanş İmamoğlu, Tülay Eren, Nuriye Yıldırım, Cengiz Karaçin, Burhan Baylan
4 Impact of comorbidities on recurrence rates and survival in patients with endometrial cancer, ANNALS OF MEDICAL RESEARCH, 27(3), 2020 Prof. Dr. Arzu Oğuz
5 The Role of Selvester Score on 12-Lead ECG in Determination of Left Ventricular Systolic Dysfunction Among Patients Receiving Trastuzumab Therapy, european journal of therapeutics, 25(1), 2019 Prof. Dr. Arzu Oğuz, Kerem Can Yılmaz, Arzu Neslihan Akgün
6 The Role of Selvester Score on 12-Lead ECG in Determination of Left Ventricular Systolic Dysfunction Among Patients Receiving Trastuzumab Therapy, european journal of therapeutics, 25(1), 2019 Kerem Can Yılmaz, Arzu Neslihan Akgün, Prof. Dr. Mustafa Yilmaz, Prof. Dr. Arzu Oğuz
7 Agranulocytosis following chemotherapy in a patient receiving clozapine treatment., Psychiatry and Clinical Psychopharmacology, 28(1), 2018 Dr. Öğr. Üyesi Selvi Ceran, Nurhak Çağatay Birer, Ali Ercan Altınöz, Prof. Dr. Arzu Oğuz
8 Treatment of Lymph Node?Negative, Early-Stage HER2-Positive Breast Cancer, JOURNAL OF CLINICAL ONCOLOGY, 34(6), 2016 Prof. Dr. Arzu Oğuz, Gül Sema Keskin, Dilşen Çolak, Prof. Dr. Özden Altundağ, Prof. Dr. Zafer Akçali
9 Dosetaxel Induced Pericardial Effusion in Two Gastric Cancer Patients, UHOD-Uluslararasi Hematoloji-Onkoloji Dergisi, 26(2), 2016 Prof. Dr. Arzu Oğuz, Doğan Yazılıtaş, Dilşen Çolak, İnanç İmamoğlu, Mustafa Altınbaş, Uğur Ersoy
10 Is Human Kallikrein 11 in Non-small Cell Lung Cancer Treated Chemoradiotherapy Associated with Survival?, Cancer Research and Treatment, 48(1), 2016 Prof. Dr. Arzu Oğuz, Mehtap Aykaç Çebicci, Serap Tomruk Sütbeyaz, Sema Sezgin Göksu, Sehriban Hocaoğlu, Ayşe Atilabey
11 Extracorporeal Shock Wave Therapy for Breast Cancer?Related Lymphedema: A Pilot Study, ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 97(9), 2016 Prof. Dr. Arzu Oğuz, Mehtap Aykaç Çebicci, Serap Tomruk Sütbeyaz, Sema Sezgin Göksu, Sehriban Hocaoğlu, Ayşe Atilabey
12 Trastuzumab in metastatic breast cancer after complete remission: How long is enough?, MEDICAL ONCOLOGY, 32(8), 2015 Prof. Dr. Arzu Oğuz, Doç. Dr. Samed Rahatli, Prof. Dr. Özden Altundağ, Kadri Altundağ
13 Hepatitis B and C Seroprevalence in Solid Tumors - Necessity for Screening During Chemotherapy, Asian Pacific Journal of Cancer Prevention, 15(3), 2014 Prof. Dr. Arzu Oğuz, Fatma Aykaş, Dilek Ünal, Samet Karahan, Emine Uslu, Mustafa Başak, Ahmet Karaman
14 Efficacy of trastuzumab-based therapy after disease progression on lapatinib based therapy in heavily pretreated HER2-positive metastatic breast cancer patients., JOURNAL OF CLINICAL ONCOLOGY, 32(0), 2014 Doğan Uncu, İbrahim Varoğlu, Ülkü Yalçıntaş, Mehmet Küçüköner, Mehmet Artaç, Doğan Koca, Prof. Dr. Arzu Oğuz, Umut Demirci, Erkan Arpacı, Mutlu Doğan, Yüksel Küçükzeybek, İbrahim Türker, Abdurrahman Işıkdoğan, Tunç Güler, Nurullah Zengin
15 Metaplastic carcinoma of the breast: A rare carcinoma with chondroid metaplasia, turkish journal of surgery, 30(1), 2014 Prof. Dr. Arzu Oğuz, Arzu Taşdemir, Dilek Ünal, Ömer Tuna
16 Is human kallikrein-11 in gastric cancer treated with surgery and adjuvant chemoradiotherapy associated with survival?, PATHOLOGY RESEARCH AND PRACTICE, 209(12), 2013 Prof. Dr. Arzu Oğuz, Dilek Ünal, Arzu Taşdemir, Cellalettin Eroğlu, Yasemin Cihan, Esra Turak, Hatice Karaman, Serdar Soyuer
17 Etoposide? Or Polysorbate 80?, indian journal of cancer, 48(0), 2011 Prof. Dr. Arzu Oğuz, Dilşen Çolak, Mustafa Altınbaş


1 Recurrence of hepatocellular carcinoma after liver transplantation: A single-center experience, 30th International Congress of The Transplantation-Society (TTS), 22.09.2024 Araş.Gör.Dr. Aydan Farzaliyeva, Araş.Gör.Dr. Mehmet Nezir Ramazanoğlu, Araş.Gör.Dr. Efe Hasdemir, Doç. Dr. Emre Karakaya, Prof. Dr. Arzu Oğuz, Prof. Dr. Zafer Akçali, Prof. Dr. Özden Altundağ, Prof. Dr. Mehmet Haberal
2 Posttransplant malignancies in adult transplant patients: A single center experience, 30th International Congress of The Transplantation-Society (TTS), 22.09.2024 Araş.Gör.Dr. Mehmet Nezir Ramazanoğlu, Araş.Gör.Dr. Aydan Farzaliyeva, Araş.Gör.Dr. Efe Hasdemir, Doç. Dr. Emre Karakaya, Doç. Dr. Samed Rahatlı, Prof. Dr. Arzu Oğuz, Prof. Dr. Zafer Akçali, Prof. Dr. Özden Altundağ, Prof. Dr. Mehmet Haberal
3 Meme Kanseriyle Birlikte Görülen Tiroid Kanserinin Osteoporoz Gelişimi İle İlişkisi, 45. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi 2024 , 19.04.2024 Araş.Gör.Dr. Ece Gül Köse Hamidi, Arş.Gör.Dr.Enes Arslanoğlu, Araş.Gör.Dr. Deniz Türküm Atikcan Şimşek, Prof. Dr. Özlem Turhan İyidir, Prof. Dr. Asli Nar, Prof. Dr. Arzu Oğuz, Prof. Dr. Neslihan Başçil Tütüncü
4 Combined versus sequential antracycline and taxane adjuvant regimens in triple negative breast cancer patients, ASCO, 12.05.2016 Gül Sema Keskin, Prof. Dr. Arzu Oğuz, Prof. Dr. Zafer Akçali, Prof. Dr. Özden Altundağ
5 Response rates of taxane rechallenge in metastatic breast cancer patients, previously treated with adjuvant taxanes., american society of clinical oncology (ASCO), 30.05.2014 Taner Babacan, Prof. Dr. Arzu Oğuz, Prof. Dr. Özden Altundağ